Speaker:
Christy Ilia


Learning Objectives:

• Describe the pathophysiology and current management of sickle cell disease (SCD) and beta-thalassemia
• Assess the risks and benefits of currently available gene therapy options for SCD and beta-thalassemia
• Evaluate the current and future role of gene therapy on clinical practice and disease management

Disclosure:
Christy has no relevant financial relationships to disclose.